RFG Bristol Wealth Advisors LLC Makes New $565,000 Investment in Medline $MDLN

RFG Bristol Wealth Advisors LLC bought a new position in shares of Medline (NASDAQ:MDLN) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 12,690 shares of the company’s stock, valued at approximately $565,000.

Other large investors have also added to or reduced their stakes in the company. Sound Income Strategies LLC purchased a new position in shares of Medline in the fourth quarter worth about $25,000. Entrust Financial LLC purchased a new stake in Medline in the fourth quarter valued at approximately $26,000. NBC Securities Inc. purchased a new stake in Medline in the fourth quarter valued at approximately $28,000. Whipplewood Advisors LLC acquired a new position in Medline in the 1st quarter worth approximately $30,000. Finally, Global Retirement Partners LLC purchased a new position in Medline during the 4th quarter worth approximately $31,000.

Insider Buying and Selling

In other news, insider Douglas P. Golwas sold 100,000 shares of the stock in a transaction that occurred on Tuesday, June 16th. The stock was sold at an average price of $36.77, for a total transaction of $3,677,000.00. Following the transaction, the insider owned 23,899 shares in the company, valued at $878,766.23. This trade represents a 80.71% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Jessi L. Corcoran acquired 5,000 shares of Medline stock in a transaction on Friday, June 5th. The shares were bought at an average price of $34.15 per share, with a total value of $170,750.00. Following the completion of the transaction, the insider directly owned 5,000 shares of the company’s stock, valued at $170,750. This trade represents a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Company insiders own 0.81% of the company’s stock.

Medline Trading Up 2.0%

Shares of Medline stock opened at $39.44 on Thursday. The company has a market cap of $51.81 billion and a P/E ratio of 123.25. Medline has a fifty-two week low of $32.81 and a fifty-two week high of $50.88. The company has a debt-to-equity ratio of 0.65, a quick ratio of 2.51 and a current ratio of 4.41. The firm has a 50-day simple moving average of $37.80 and a two-hundred day simple moving average of $42.08.

Medline (NASDAQ:MDLN) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.04. The business had revenue of $7.35 billion for the quarter. The company’s quarterly revenue was up 10.7% on a year-over-year basis. As a group, equities analysts predict that Medline will post 1.49 earnings per share for the current fiscal year.

Analysts Set New Price Targets

MDLN has been the subject of several research reports. Robert W. Baird decreased their price objective on shares of Medline from $57.00 to $45.00 and set an “outperform” rating for the company in a research note on Wednesday, June 3rd. Deutsche Bank Aktiengesellschaft set a $42.00 target price on shares of Medline in a report on Thursday, May 7th. BTIG Research restated a “buy” rating and set a $55.00 target price on shares of Medline in a research report on Thursday, May 7th. Weiss Ratings downgraded Medline from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, May 15th. Finally, Tigress Financial lifted their price objective on Medline from $60.00 to $62.00 and gave the company a “buy” rating in a research note on Wednesday, May 13th. One analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Medline has an average rating of “Moderate Buy” and an average price target of $50.54.

About Medline

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply‑chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.